Bristol-Myers Squibb Company is dedicated to the discovery, development and exploration of cancer fighting therapies that extend and enhance the lives of patients living with cancer. More than 40 years ago, Bristol-Myers Squibb built a unified vision for the future of cancer treatment. With experience, dedication and resolve, that vision led to the development of a diverse worldwide portfolio of anticancer therapies that are an important cornerstone of care today. Scientists at Bristol-Myers Squibbs Pharmaceutical Research Institute are studying ways to improve current cancer treatments and identify better, more effective medicines for the future. James M. Cornelius was elected chief executive officer of Bristol-Myers Squibb by the company s Board of Directors in April 2007, after serving as interim CEO since September 2006. Headquartered in New York, Bristol-Myers Squibb Company is a worldwide pharmaceutical and related health care-products company whose mission is to extend and enhance human life.